Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/193904
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy |
Autor: | Silkenstedt, Elisabeth; Arenas, Fabian CSIC ORCID; Colom-Sanmartí, Berta; Xargay-Torrent, Sílvia; Higashi, Morihiro; Giró, Ariadna; Rodriguez, Vanina; Fuentes, Patricia; Aulitzky, Walter E; van der Kuip, Heiko; Beà, Silvia; Toribio, María Luisa CSIC ORCID; Campo, Elías; López-Guerra, Mònica; Colomer, Dolors | Palabras clave: | Mantle cell lymphoma Notch1 Delta-like ligand Angiogenesis OMP-52 M51 |
Fecha de publicación: | 1-nov-2019 | Editor: | BioMed Central | Citación: | Journal of Experimental & Clinical Cancer Research 38(1): 446 (2019) | Resumen: | [Background]: NOTCH1 gene mutations in mantle cell lymphoma (MCL) have been described in about 5–10% of cases and are associated with significantly shorter survival rates. The present study aimed to investigate the biological impact of this mutation in MCL and its potential as a therapeutic target. [Methods]: Activation of Notch1 signaling upon ligand-stimulation and inhibitory effects of the monoclonal anti-Notch1 antibody OMP-52M51 in NOTCH1-mutated and -unmutated MCL cells were assessed by Western Blot and gene expression profiling. Effects of OMP-52M51 treatment on tumor cell migration and tumor angiogenesis were evaluated with chemotaxis and HUVEC tube formation assays. The expression of Delta-like ligand 4 (DLL4) in MCL lymph nodes was analyzed by immunofluorescence staining and confocal microscopy. A MCL mouse model was used to assess the activity of OMP-52M51 in vivo. [Results]: Notch1 expression can be effectively stimulated in NOTCH1-mutated Mino cells by DLL4, whereas in the NOTCH1-unmutated cell line JeKo-1, less effect was observed upon any ligand-stimulation. DLL4 was expressed by histiocytes in both, NOTCH1-mutated and –unmutated MCL lymph nodes. Treatment of NOTCH1-mutated MCL cells with the monoclonal anti-Notch1 antibody OMP-52M51 effectively prevented DLL4-dependent activation of Notch1 and suppressed the induction of numerous direct Notch target genes involved in lymphoid biology, lymphomagenesis and disease progression. Importantly, in lymph nodes from primary MCL cases with NOTCH1/2 mutations, we detected an upregulation of the same gene sets as observed in DLL4-stimulated Mino cells. Furthermore, DLL4 stimulation of NOTCH1-mutated Mino cells enhanced tumor cell migration and angiogenesis, which could be abolished by treatment with OMP-52M51. Importantly, the effects observed were specific for NOTCH1-mutated cells as they did not occur in the NOTCH1-wt cell line JeKo-1. Finally, we confirmed the potential activity of OMP-52M51 to inhibit DLL4-induced Notch1-Signaling in vivo in a xenograft mouse model of MCL. [Conclusion]: DLL4 effectively stimulates Notch1 signaling in NOTCH1-mutated MCL and is expressed by the microenvironment in MCL lymph nodes. Our results indicate that specific inhibition of the Notch1-ligand-receptor interaction might provide a therapeutic alternative for a subset of MCL patients. |
Descripción: | The Author(s). | Versión del editor: | https://doi.org/10.1186/s13046-019-1458-7 | URI: | http://hdl.handle.net/10261/193904 | DOI: | 10.1186/s13046-019-1458-7 | ISSN: | 0392-9078 | E-ISSN: | 1756-9966 |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Notch1_Silkenstedt.pdf | 2,47 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
15
checked on 11-abr-2024
SCOPUSTM
Citations
25
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
26
checked on 23-feb-2024
Page view(s)
221
checked on 23-abr-2024
Download(s)
125
checked on 23-abr-2024